Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perindopril in Obese Subjects
NCT02777489Phase 2Terminated
- Sponsor
- Gene PreDiT
- Start
- Feb 2016
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of perindopril in obesity, sponsored by Gene PreDiT. Started Feb 2016; status: terminated.
02
Drugs
perindopril
03
Conditions
obesity
Beyond the preview
Go deeper on NCT02777489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02777489.